lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
PTC THERAPEUTICS, INC.
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference
January 12, 2026
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 8, 2026
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan
December 22, 2025
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 21, 2025
PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 20, 2025